(Fighting New Coronary Pneumonia) Pfizer vaccine is the first to be approved for use in children aged 5 to 11 in Canada
China News Service, Toronto, November 20 (Reporter Yu Ruidong) The Canadian Ministry of Health announced on November 19 that it has approved the use of the new coronavirus vaccine developed by Pfizer in cooperation with the German Biotech Company (Pfizer for short) in children aged 5 to 11 years old. vaccine).
Pfizer vaccine has therefore become the first new coronavirus vaccine approved in Canada that can be used for low-age people.
The Canadian Ministry of Health received an application from Pfizer and the German Biotech Company to expand its vaccine application population a month ago.
Pfizer vaccine was first approved in Canada in December 2020 for people aged 16 and over, and was approved for people aged 12 to 15 in May of this year.
Ten days ago, the Canadian Ministry of Health approved the vaccine as a booster, that is, the third dose for adults 18 years and older.
The Canadian Ministry of Health stated that after a comprehensive and independent scientific review, it has been determined that the benefits of Pfizer vaccine for children aged 5 to 11 outweigh the risks. The effectiveness of preventing new coronavirus infection is 90.7%, and no serious side effects have been found.
The officially approved Pfizer vaccine dose for children 5 to 11 years old is two doses of 10 micrograms each, three weeks apart.
The injection dose for people 12 years and older is 30 micrograms per dose.
In addition, the American pharmaceutical company Modena has recently applied to the Canadian government for authorization to use its new crown vaccine for children aged 6 to 11.
This is the second application received by the Canadian Ministry of Health for the use of the new crown vaccine for lower age groups.
The new crown vaccines currently approved by the Canadian government include Pfizer, Modena, AstraZeneca and Johnson & Johnson.
Over 89% of Canadians over the age of 12 have received at least one dose of the new crown vaccine.
Of the country's total population, more than 78% have received at least one dose of the vaccine, and more than 75% have achieved full dose vaccination.
As of the evening of November 19, the cumulative number of confirmed cases in Canada exceeded 1.762 million, with 2875 newly confirmed cases that day; 29,481 deaths and 23,841 active cases.
The number of new daily cases nationwide has shown a slow downward trend, but there are still some provinces in which the recent epidemic has rebounded slightly or maintained a high infection rate.
(over)